Professor Marshall Continues to Propel Ace Vision Group Forward
Ace Vision Group, Inc., an emerging medical device company at the forefront of pioneering rejuvenation therapy for the aging eye, today announced that it has named John Marshall, PhD, FRCPath, FMedSc as Scientific Advisor of Laser Technology. Professor Marshall is a pioneer of laser eye surgery, having developed computer-controlled excimer lasers for the correction of human refractive errors, creating a new field of eye surgery. He then cofounded the first company to receive Food and Drug Administration (FDA) approval for laser refractive surgery. His significant contributions also include the development of the first diode laser for various eye conditions, including those associated with diabetes and aging.
Explore More Articles
Robert Ang Discusses LSM by Ace Vision
Robert T. Ang, refractive surgeon at the Asian Eye Institute in the Philippines, talks to The Ophthalmologist about the ways Laser Scleral Microporation (LSM) therapy offered by Ace Vision Group comes to benefit him and his patients. He discusses the therapy’s mechanism of action, what the procedure involves, and the unique value offered by LSM. …
read moreLaser scleral microporation may solve biomechanical problem of presbyopia
CHICAGO — In this Healio Video Perspective from Eyecelerator@AAO, Alex Lopez of Ace Vision Group discusses laser scleral microporation for presbyopia. Lopez said the GenII device can potentially deliver improved near vision without compromising distance vision in patients with presbyopia. The company plans to do a study in the United States in 2026, potentially leading to commercial availability in …
read moreNew-generation software further improves precision of laser scleral microporation
VIENNA — In this Healio Video Perspective from the ESCRS meeting, Luca Gualdi, MD, speaks about the latest advances in laser scleral microporation. Laser scleral microporation (LSM, Ace Vision Group) is a treatment that restores accommodation in presbyopic patients by uncross-linking the scleral tissue that becomes stiff with age. It does so by performing arrays of micropores in …
read more